Tech Transfer

Strathclyde books in Listings Ledger
Listings Ledger has spun out from the university to commercialise a real-time valuation ticker for privately-owned companies.
NetScientific to delist from Aim
Commercialisation firm NetScientific will delist from Aim to free up cash for its portfolio companies, having failed to attract concrete offers after putting itself up for an acquisition.
Karolinska Development portfolio value gains one third
The gains came against a backdrop of falling net profits and cash reserves that will test Karolinska Development as it looks ahead to convertible debt obligations.
Insignals flexes its muscles
Spun out of Inesc Tec under a strategic agreement with Frontier IP, Insignals hopes to commercialise a surgical guidance device for brain implants to treat conditions including Parkinson's.
IU commences dig at the Quarry
Indiana University has retooled its entrepreneurial support offering to enhance its services in business case development, executive recruitment and the sourcing of capital.
Recida rolls out from Frazier Healthcare
Venture capital firm Frazier Healthcare Partners has spun out a US-based antibiotics developer with the help of grant funding from a Boston University-operated body and a $8.5m series A round.
MIT springs drug-delivery spinout
MIT has launched an as-yet unnamed spinout to develop a smart drug-delivery pill to help plan more effective treatment regimens for patients.
Blue Water seeks $15m injection
US-based Blue Water Vaccines has an option on University of Oxford research into a universal influenza shot and is looking to raise $15m in funding.

Other News

NovaUCD signs up student-founded duo
Evervault is pursuing seed funding for encryption software that protects compromised networks, while MyStudyPal has launched an academic timetabling app.
OUI spuds 24 spinouts in 2018
Oxford University Innovation reported a record $698m of funding for its portfolio businesses in a year which brought its total number of spinouts to more than 170.
UNLV touts Food Genes and Me
Dietary suggestion software spinout Food Genes and Me compiles personalised healthy eating tips based on uploaded DNA reports from external genetic analysis tools.
NYU and Futurx spark Glixogen’s genesis
New York University has teamed up with corporate-backed biopharmaceutical incubator Futurx to spawn neurodegenerative disease drug developer Glixogen Therapeutics.
Purdue breaks through 200 companies
The university has helped launch 223 businesses, including 130 based on its IP, since an overhaul of its commercialisation strategy in 2013.
Washington likes the look of Neoleukin
Immunooncology spinout Neoleukin Therapeutics is working on a safer, synthetic replica of a T-cell-boosting protein called interleukin-2.

Editor's Picks

Big deal: Ambys arrives at $140m investment
Ambys Medicines has raised $60m in a series A round backed by Takeda and signed a strategic partnership agreement with the corporate worth $80m.
Taking a leap towards the quantum future
Isis Innovation's Rakesh Roshan investigates the looming age of quantum computing.
12 spin-outs of Christmas
GUV's list of hot spin-outs to watch in 2015.
test reg